Join us   Log in  

PHARMASPIRE - Volume 12, Issue 3, July-September, 2020

Pages: 89-95

Date of Publication: 10-Jun-2022

Print Article   Download XML  Download PDF

Novel coronavirus: Pathophysiology, symptoms, diagnosis, and management

Author: Suyash Agnihotri, Saranjit Singh, Haamid Rasheed, Sukhbir Kaur

Category: Pharmaceutics


Epidemically increased evidence reveals that the novel coronavirus (COVID-19) virus belongs to the class of severe acute respiratory syndrome and the Middle East Respiratory Syndrome virus. Covid-19 was started from the Wuhan city of China in 2019, and now it gradually affecting the whole world. In this paper, the pathophysiology, symptoms, diagnosis and management of the Covid-19 is discussed briefly. Diagnostic methods used for Covid-19 are serology, and nucleic acid amplification test (NAAT). These tests are done as per the guidelines of World Health Organization (WHO).

Keywords: Novel coronavirus, severe acute respiratory syndrome, path physiology, serology, diagnostic methods, World Health Organizatio


1. Thomson S, Foubister T, Mossialos E. Financing Health Care in the European Union: Challenges and Policy Responses. Geneva: World Health Organization, Regional Office for Europe; 2009.

2. Simms MC, Myers SL. The Economics of Race and Crime. United States: Transaction Publishers; 1988.

3. Tatem AJ, Rogers DJ, Hay SI. Global transport networks, and infectious disease spread. Adv Parasitol 2006;62:293-343.

4. Levy MM, Baylor MS, Bernard GR, Fowler R, Franks TJ, Hayden FG, et al. Clinical issues and research in respiratory failure from severe acute respiratory syndrome. Am J Respir Crit Care Med 2005;171:518-26.

5. Singh AK, Singh A, Shaikh A, Singh R, Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr 2020;14:241-6.

6. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res 2020;7:1-10.

7. Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close? Autoimmun Rev 2020;19:102523.

8. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 2020;11:1-12.

9. Zhou Y, Lu K, Pfefferle S, Bertram S, Glowacka I, Drosten C, et al. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms. J Virol 2010;84:8753-64.

10. Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: Observations and hypotheses. Lancet 2020;395:1517-20.

11. Ji HL, Zhao R, Matalon S, Matthay MA. Elevated plasmin (ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev 2020;100:1065-75.

12. Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: Lessons from other pathogenic viruses. Emerg Microbes Infect 2020;9:558-70.

13. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020;109:102433.

14. Zhou D, Dai SM, Tong Q. COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother 2020;75:1667-70.

15. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-60.

16. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis 2020;20:698-96.

17. Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 2020;63:706-11.

18. Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, Sun R, Wang Y, Hu B, Chen W, Zhang Y. Development and clinical application of a rapid IgM?IgG combined antibody test for SARS?CoV?2 infection diagnosis. J Med Virol 2020;2020:25727.

19. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 2020;92:589-94.

20. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020;87:281-6.

21. World Health Organization. Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases: Interim Guidance. Geneva: World Health Organization; 2020.

22. Lieberman D, Shleyfer E, Castel H, Terry A, Harman-Boehm I, Delgado J, et al. Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adults. J Clin Microbiol 2006;44:525-8.

23. Winichakoon P, Chaiwarith R, Liwsrisakun C, Salee P, Goonna A, LimsukonA, et al. Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19. J Clin Microbiol 2020;58:e00297-20.

24. Hopman J, Allegranzi B, Mehtar S. Managing COVID-19 in low-and middleincome countries. JAMA 2020;323:1549-50.

25. World Health Organization. Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-care Settings, with Focus on Ebola. Geneva: World Health Organization; 2014.

26. World Health Organization. Considerations for Quarantine of Individuals in the Context of Containment for Coronavirus Disease (COVID-19): Interim Guidance. Geneva: World Health Organization; 2020.

27. World Health Organization. Protocol for Assessment of Potential Risk Factors for Coronavirus Disease 2019 (COVID-19) Among Health Workers in a Health Care Setting. Geneva: World Health Organization; 2020.

28. Barbisch D, Koenig KL, Shih FY. Is there a case for quarantine? Perspectives from SARS to Ebola. Disaster Med Public Health Prep 2015;9:547-53.

29. Day MJ. Covid-19: Identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ 2020;368:m1165.

30. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, et al. Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-54.

31. Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet 2020;395:1137-44.

32. Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health 2020;8:e488-96.

33. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846-8.

34. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19), in Statpearls. Treasure Island, FL: StatPearls Publishing; 2020.

35. Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty 2020;9:1-12.

36. Bhattacharya S, Sharma P, Mathur H, Rasheed H, Singh S, Rajput G, et al. Recent apprise on coronavirus and its terrible insinuations. Virusdisease 2020;31:1-7.

37. Wyndham DJ. Misdiagnosis or miscarriage of justice? Dr. Norman haire and the 1919 influenza epidemic at newcastle hospital. Health Hist 2000;2:3-26.

38. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13.

39. Khan N, Naushad M. Effects of Corona Virus on the World Community. SSRN Electron J 2020;2020:2139.